The risk or severity of adverse effects can be increased when oxazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when propantheline is combined with Tapentadol.


The risk or severity of adverse effects can be increased when desipramine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with nimesulide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when temazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with doxepin.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with floctafenine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when triazolam is combined with etizolam.


The risk or severity of adverse effects can be increased when meperidine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Lomitapide.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when valsartan is combined with nimodipine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when tropicamide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when clorazepate is combined with quetiapine.


The risk or severity of adverse effects can be increased when pergolide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when triprolidine is combined with clonidine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with physostigmine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when lidocaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when haloperidol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Agomelatine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when nicergoline is combined with lomustine.


The risk or severity of adverse effects can be increased when nicergoline is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when morniflumate is combined with Propacetamol.


The risk or severity of adverse effects can be increased when clorazepate is combined with ketamine.


The risk or severity of adverse effects can be increased when captopril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when codeine is combined with olanzapine.


The risk or severity of adverse effects can be increased when indapamide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Droxicam is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when pergolide is combined with ifosfamide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when propantheline is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when halcinonide is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when triazolam is combined with butamben.


The risk or severity of adverse effects can be increased when thiopental is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with nefazodone.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with nefazodone.


The risk or severity of adverse effects can be increased when prazosin is combined with captopril.


The risk or severity of adverse effects can be increased when Nilotinib is combined with leflunomide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when amiodarone is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when isoflurane is combined with Flibanserin.


The risk or severity of adverse effects can be increased when clorazepate is combined with zaleplon.


The risk or severity of adverse effects can be increased when tizanidine is combined with meclizine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when nicergoline is combined with resveratrol.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when spironolactone is combined with indapamide.


The risk or severity of adverse effects can be increased when clozapine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when clozapine is combined with topiramate.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when citalopram is combined with Eletriptan.


The risk or severity of adverse effects can be increased when Nepafenac is combined with celecoxib.


The risk or severity of adverse effects can be increased when Eprosartan is combined with acebutolol.


The risk or severity of adverse effects can be increased when metoprolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Eprosartan is combined with captopril.


The risk or severity of adverse effects can be increased when butabarbital is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when tolnaftate is combined with isradipine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when bromocriptine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when codeine is combined with thiopental.


The risk or severity of adverse effects can be increased when amisulpride is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with thiothixene.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Aliskiren.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with fenbufen.


The risk or severity of adverse effects can be increased when nitrazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when temazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with gabapentin.


The risk or severity of adverse effects can be increased when fluocinonide is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with Milnacipran.


The risk or severity of adverse effects can be increased when docetaxel is combined with fleroxacin.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with diflorasone.


The risk or severity of adverse effects can be increased when docetaxel is combined with thiotepa.


The risk or severity of adverse effects can be increased when prilocaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when fenbufen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with cetirizine.


The risk or severity of adverse effects can be increased when biperiden is combined with Tramadol.


The risk or severity of adverse effects can be increased when buspirone is combined with pentazocine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with haloperidol.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when triflupromazine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxybutynin is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with triprolidine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with meclizine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with doxepin.


The risk or severity of adverse effects can be increased when buspirone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when levorphanol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when butenafine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when oxaprozin is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when chloroquine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when rescinnamine is combined with ibuprofen.


The risk or severity of adverse effects can be increased when diclofenac is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when fosinopril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with apraclonidine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with sertraline.


The risk or severity of adverse effects can be increased when trimeprazine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when meperidine is combined with triazolam.


The risk or severity of adverse effects can be increased when flurazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with pentazocine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with thiamylal.


The risk or severity of adverse effects can be increased when nalbuphine is combined with desipramine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when selegiline is combined with dobutamine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when protriptyline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when valsartan is combined with indapamide.


The risk or severity of adverse effects can be increased when amisulpride is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with bumetanide.


The risk or severity of adverse effects can be increased when lorazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when estazolam is combined with clidinium.


The risk or severity of adverse effects can be increased when methysergide is combined with lansoprazole.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when loxapine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ramipril is combined with nimodipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when reserpine is combined with trimipramine.


The risk or severity of adverse effects can be increased when reserpine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when irbesartan is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when reserpine is combined with lisinopril.


The risk or severity of adverse effects can be increased when reserpine is combined with procaine.


The risk or severity of adverse effects can be increased when minoxidil is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when captopril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when cetirizine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with halothane.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Bretylium.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when salicylic acid is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with trimipramine.


The risk or severity of adverse effects can be increased when meclizine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with procaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with felbamate.


The risk or severity of adverse effects can be increased when benazepril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with efavirenz.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Clobetasone.


The risk or severity of adverse effects can be increased when oxazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when oxazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when metaraminol is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when ketorolac is combined with tolmetin.


The risk or severity of adverse effects can be increased when ketorolac is combined with haloperidol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with clonidine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with oxaprozin.


The risk or severity of adverse effects can be increased when etodolac is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when prazosin is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when methysergide is combined with manidipine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with felbamate.


The risk or severity of adverse effects can be increased when amcinonide is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Ramelteon is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Melatonin is combined with maprotiline.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with enalapril.


The risk or severity of adverse effects can be increased when budesonide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when griseofulvin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when captopril is combined with nimesulide.


The risk or severity of adverse effects can be increased when isradipine is combined with papaverine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with D-mannitol.


The risk or severity of adverse effects can be increased when isradipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with etodolac.


The risk or severity of adverse effects can be increased when oxycodone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when cocaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when lorazepam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when timolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when aminophylline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when quetiapine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Torasemide is combined with tobramycin.


The risk or severity of adverse effects can be increased when carprofen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when celecoxib is combined with Halobetasol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ritodrine.


The risk or severity of adverse effects can be increased when celecoxib is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when oxazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with GLYCEROL PHENYLBUTYRATE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when oxazepam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when doxazosin is combined with terazosin.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Temsirolimus is combined with Sunitinib.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when olanzapine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when benazepril is combined with terazosin.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with morphine.


The risk or severity of adverse effects can be increased when suprofen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when sulindac is combined with Clobetasone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when miconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when suprofen is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with felodipine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when celecoxib is combined with triamcinolone.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with clonidine.


The risk or severity of adverse effects can be increased when meclizine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when estrone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when midazolam is combined with HEROIN.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with equilin.


The risk or severity of adverse effects can be increased when thiopental is combined with Butethal.


The risk or severity of adverse effects can be increased when lidocaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiopental is combined with lithium ion.


The risk or severity of adverse effects can be increased when thiopental is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when cabergoline is combined with tioconazole.


The risk or severity of adverse effects can be increased when secobarbital is combined with etizolam.


The risk or severity of adverse effects can be increased when timolol is combined with felodipine.


The risk or severity of adverse effects can be increased when timolol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Bretylium.


The risk or severity of adverse effects can be increased when diltiazem is combined with Riociguat.


The risk or severity of adverse effects can be increased when timolol is combined with irbesartan.


The risk or severity of adverse effects can be increased when dyclonine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when sumatriptan is combined with haloperidol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Amrinone.


The risk or severity of adverse effects can be increased when Agomelatine is combined with zonisamide.


The risk or severity of adverse effects can be increased when levorphanol is combined with gabapentin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with fosinopril.


The risk or severity of adverse effects can be increased when ethanol is combined with nicotinic acid.


The risk or severity of adverse effects can be increased when Agomelatine is combined with tiagabine.


The risk or severity of adverse effects can be increased when tetracaine is combined with levodopa.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with deslanoside.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Salsalate.


The risk or severity of adverse effects can be increased when difluprednate is combined with galanthamine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when difluprednate is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when procaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when procaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when alclofenac is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Lopinavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when oxycodone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Butethal is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with levodopa.


The risk or severity of adverse effects can be increased when terbinafine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when secobarbital is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when baclofen is combined with citalopram.


The risk or severity of adverse effects can be increased when Pramocaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when betaxolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when hydroxychloroquine is combined with dapsone.


The risk or severity of adverse effects can be increased when etizolam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Etomidate is combined with Articaine.


The risk or severity of adverse effects can be increased when cabergoline is combined with sumatriptan.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when butabarbital is combined with lithium ion.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when butabarbital is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when butabarbital is combined with amobarbital.


The risk or severity of adverse effects can be increased when butabarbital is combined with Butethal.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Halazepam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with efavirenz.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with cilostazol.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when atenolol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when duloxetine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Remoxipride is combined with meclizine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when nevirapine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Pizotifen is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with promazine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when meperidine is combined with Asenapine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when meperidine is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when cocaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with tiagabine.


The risk or severity of adverse effects can be increased when meprobamate is combined with clomipramine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with antipyrine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Pemetrexed is combined with leflunomide.


The risk or severity of adverse effects can be increased when tetracaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Perospirone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tetracaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when tolmetin is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Telmisartan is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with levodopa.


The risk or severity of adverse effects can be increased when nitrendipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with decamethonium.


The risk or severity of adverse effects can be increased when milrinone is combined with aspirin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Pemetrexed.


The risk or severity of adverse effects can be increased when docetaxel is combined with mebendazole.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with dantrolene.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with citalopram.


The risk or severity of adverse effects can be increased when lorazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with doxepin.


The risk or severity of adverse effects can be increased when antipyrine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with cetirizine.


The risk or severity of adverse effects can be increased when bifonazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when diltiazem is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with furosemide.


The risk or severity of adverse effects can be increased when olanzapine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when reserpine is combined with papaverine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with phentolamine.


The risk or severity of adverse effects can be increased when lithium ion is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when rapamycin is combined with benazepril.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with glutethimide.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with sertraline.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with hydralazine.


The risk or severity of adverse effects can be increased when phenytoin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when pimozide is combined with Halazepam.


The risk or severity of adverse effects can be increased when bepridil is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when pimozide is combined with proparacaine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with lovastatin.


The risk or severity of adverse effects can be increased when promazine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Tapentadol is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when levodopa is combined with moclobemide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Halazepam.


The risk or severity of adverse effects can be increased when levodopa is combined with Escitalopram.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with risperidone.


The risk or severity of adverse effects can be increased when diazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when sulfapyridine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when metoprolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when procarbazine is combined with brimonidine.


The risk or severity of adverse effects can be increased when pargyline is combined with Bambuterol.


The risk or severity of adverse effects can be increased when Pentolinium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with benazepril.


The risk or severity of adverse effects can be increased when pargyline is combined with clenbuterol.


The risk or severity of adverse effects can be increased when methadone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Tiotropium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with morphine.


The risk or severity of adverse effects can be increased when Pregabalin is combined with lovastatin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with fosinopril.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when nicardipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when nicardipine is combined with methyldopa.


The risk or severity of adverse effects can be increased when cilazapril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when rasagiline is combined with zotepine.


The risk or severity of adverse effects can be increased when Propiverine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when carprofen is combined with ibuprofen.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Spirapril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Bortezomib is combined with ILOPROST.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Naftifine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with trazodone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with thalidomide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with tiagabine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when alclofenac is combined with acemetacin.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with carvedilol.


The risk or severity of adverse effects can be increased when diazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when enalapril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when baclofen is combined with maprotiline.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with ondansetron.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with dantrolene.


The risk or severity of adverse effects can be increased when sulpiride is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when sulpiride is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with lisinopril.


The risk or severity of adverse effects can be increased when lisinopril is combined with resveratrol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with desipramine.


The risk or severity of adverse effects can be increased when butorphanol is combined with thioridazine.


The risk or severity of adverse effects can be increased when resveratrol is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when buspirone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with Retigabine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with azelastine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when bromocriptine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when reserpine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when procyclidine is combined with scopolamine.


The risk or severity of adverse effects can be increased when fosinopril is combined with benazepril.


The risk or severity of adverse effects can be increased when methylergonovine is combined with vincristine.


The risk or severity of adverse effects can be increased when amiodarone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Naftifine is combined with Icatibant.


The risk or severity of adverse effects can be increased when sulindac is combined with haloperidol.


The risk or severity of adverse effects can be increased when oxiconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcifediol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tofisopam.


The risk or severity of adverse effects can be increased when Pregabalin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when terconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when ketamine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when clonidine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when ketamine is combined with glutethimide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when Torasemide is combined with plicamycin.


The risk or severity of adverse effects can be increased when reserpine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Spirapril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when perphenazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Pipamperone is combined with timolol.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with etizolam.


The risk or severity of adverse effects can be increased when Flupentixol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when prazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when propofol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when bromocriptine is combined with minoxidil.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with mefloquine.


The risk or severity of adverse effects can be increased when enalapril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Lurasidone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when pirenzepine is combined with topiramate.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when scopolamine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when resveratrol is combined with Droxicam.


The risk or severity of adverse effects can be increased when nitrendipine is combined with ropinirole.


The risk or severity of adverse effects can be increased when resveratrol is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when nitrendipine is combined with metoprolol.


The risk or severity of adverse effects can be increased when diflunisal is combined with triamcinolone.


The risk or severity of adverse effects can be increased when clotrimazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when valsartan is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when isoflurane is combined with zonisamide.


The risk or severity of adverse effects can be increased when levorphanol is combined with triamterene.


The risk or severity of adverse effects can be increased when acebutolol is combined with nadolol.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when nefazodone is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Etomidate is combined with Ramelteon.


The risk or severity of adverse effects can be increased when prilocaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when prilocaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with tiapride.


The risk or severity of adverse effects can be increased when Icatibant is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with zopiclone.


The risk or severity of adverse effects can be increased when hexetidine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when acebutolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nitric oxide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when Articaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Asenapine.


The risk or severity of adverse effects can be increased when Articaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with trimipramine.


The risk or severity of adverse effects can be increased when perphenazine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Milnacipran.


The risk or severity of adverse effects can be increased when flurazepam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when atenolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ramipril.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with estrone.


The risk or severity of adverse effects can be increased when furazolidone is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when atenolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Etomidate is combined with Tolcapone.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with nicardipine.


The risk or severity of adverse effects can be increased when mefloquine is combined with acetylcholine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Articaine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when levorphanol is combined with benzocaine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Droxicam.


The risk or severity of adverse effects can be increased when Butoconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Droxicam.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Naftifine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when lorazepam is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with apraclonidine.


The risk or severity of adverse effects can be increased when butenafine is combined with nifedipine.


The risk or severity of adverse effects can be increased when methazolamide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when codeine is combined with tetracaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Stepronin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with diazepam.


The risk or severity of adverse effects can be increased when nortriptyline is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when triazolam is combined with citalopram.


The risk or severity of adverse effects can be increased when Dothiepin is combined with citalopram.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Tadalafil.


The risk or severity of adverse effects can be increased when cabergoline is combined with Elbasvir.


The risk or severity of adverse effects can be increased when lorazepam is combined with clorazepate.


The risk or severity of adverse effects can be increased when metolazone is combined with carbamazepine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with trimipramine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with spironolactone.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when nimesulide is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when nimesulide is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with clemastine.


The risk or severity of adverse effects can be increased when doxepin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when azelastine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Perampanel is combined with duloxetine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Perospirone.


The risk or severity of adverse effects can be increased when Propacetamol is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Perampanel is combined with fluoxetine.


The risk or severity of adverse effects can be increased when carvedilol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Propacetamol is combined with amcinonide.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when methysergide is combined with nicotinamide.


The risk or severity of adverse effects can be increased when Trabectedin is combined with clozapine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with oxybutynin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when nimodipine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with ethotoin.


The risk or severity of adverse effects can be increased when salicylamide is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when salicylamide is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with butalbital.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cabergoline is combined with triflupromazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when pramipexole is combined with Olmesartan.


The risk or severity of adverse effects can be increased when hydromorphone is combined with tizanidine.


The risk or severity of adverse effects can be increased when pramipexole is combined with isradipine.


The risk or severity of adverse effects can be increased when mesalamine is combined with haloperidol.


The risk or severity of adverse effects can be increased when amobarbital is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when cabergoline is combined with ritonavir.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with oxybutynin.


The risk or severity of adverse effects can be increased when cabergoline is combined with anastrozole.


The risk or severity of adverse effects can be increased when Etomidate is combined with prazepam.


The risk or severity of adverse effects can be increased when erythromycin is combined with oxycodone.


The risk or severity of adverse effects can be increased when Etomidate is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when reserpine is combined with prazepam.


The risk or severity of adverse effects can be increased when carprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when betamethasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when procarbazine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when carprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when propofol is combined with topiramate.


The risk or severity of adverse effects can be increased when Pentolinium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when propofol is combined with Olmesartan.


The risk or severity of adverse effects can be increased when phentolamine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Bivalirudin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when MELPERONE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Asenapine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with metolazone.


The risk or severity of adverse effects can be increased when triazolam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when triazolam is combined with zaleplon.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with dibucaine.


The risk or severity of adverse effects can be increased when ramipril is combined with Apremilast.


The risk or severity of adverse effects can be increased when ethosuximide is combined with zonisamide.


The risk or severity of adverse effects can be increased when Apremilast is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when ethosuximide is combined with tiagabine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with duloxetine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when loxapine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when azelastine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when floctafenine is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with nefazodone.


The risk or severity of adverse effects can be increased when donepezil is combined with acetylcholine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Nabilone is combined with carvedilol.


The risk or severity of adverse effects can be increased when docetaxel is combined with floxuridine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when carbamazepine is combined with pentazocine.


The risk or severity of adverse effects can be increased when tropicamide is combined with morphine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Nabilone is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when amiodarone is combined with terazosin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when medrysone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when medrysone is combined with galanthamine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with metolazone.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Clevidipine.


The risk or severity of adverse effects can be increased when sulconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when risperidone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when propofol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Conivaptan is combined with valsartan.


The risk or severity of adverse effects can be increased when Conivaptan is combined with ramipril.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Articaine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with equilin.


The risk or severity of adverse effects can be increased when oxycodone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when risperidone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when diflunisal is combined with fenbufen.


The risk or severity of adverse effects can be increased when ibuprofen is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with methadone.


The risk or severity of adverse effects can be increased when zopiclone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when diflunisal is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Butethal is combined with clonidine.


The risk or severity of adverse effects can be increased when thalidomide is combined with metoprolol.


The risk or severity of adverse effects can be increased when ketamine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when cabergoline is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when ketamine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when amifostine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when codeine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with propofol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with acetazolamide.


The risk or severity of adverse effects can be increased when dyclonine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when bromazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when thiamylal is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with captopril.


The risk or severity of adverse effects can be increased when codeine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when azelastine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when labetalol is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when celiprolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when morphine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Bretylium.


The risk or severity of adverse effects can be increased when morphine is combined with tiapride.


The risk or severity of adverse effects can be increased when meperidine is combined with duloxetine.


The risk or severity of adverse effects can be increased when prilocaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Torasemide is combined with atenolol.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with sevoflurane.


The risk or severity of adverse effects can be increased when nilvadipine is combined with ropinirole.


The risk or severity of adverse effects can be increased when morphine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Melatonin is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with topiramate.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when pentazocine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when topiramate is combined with clomipramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nitric oxide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when oxybutynin is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when fosinopril is combined with nicardipine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Normethadone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when diclofenac is combined with carprofen.


The risk or severity of adverse effects can be increased when butorphanol is combined with Normethadone.


The risk or severity of adverse effects can be increased when meclizine is combined with promethazine.


The risk or severity of adverse effects can be increased when meclizine is combined with clonazepam.


The risk or severity of adverse effects can be increased when antipyrine is combined with resveratrol.


The risk or severity of adverse effects can be increased when bromazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when phentolamine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when bromazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when etodolac is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when metaraminol is combined with acebutolol.


The risk or severity of adverse effects can be increased when temazepam is combined with ketamine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfacetamide.


The risk or severity of adverse effects can be increased when indapamide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when milrinone is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when imipramine is combined with rasagiline.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with hydralazine.


The risk or severity of adverse effects can be increased when miconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when miconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when amisulpride is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Caspofungin is combined with eperisone.


The risk or severity of adverse effects can be increased when valsartan is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when oxybutynin is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with alclofenac.


The risk or severity of adverse effects can be increased when Normethadone is combined with phenytoin.


The risk or severity of adverse effects can be increased when indomethacin is combined with Deferasirox.


The risk or severity of adverse effects can be increased when quinidine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Tramadol is combined with Almotriptan.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when nilvadipine is combined with sotalol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with clomipramine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Nabilone is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with glimepiride.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with diflorasone.


The risk or severity of adverse effects can be increased when fenbufen is combined with equilin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when salicylamide is combined with desoximetasone.


The risk or severity of adverse effects can be increased when floctafenine is combined with flumethasone.


The risk or severity of adverse effects can be increased when epirizole is combined with estrone.


The risk or severity of adverse effects can be increased when benzocaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Etomidate.


The risk or severity of adverse effects can be increased when Eprosartan is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when etizolam is combined with clomipramine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ritonavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when irinotecan is combined with atorvastatin.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with penbutolol.


The risk or severity of adverse effects can be increased when secobarbital is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Torasemide is combined with indapamide.


The risk or severity of adverse effects can be increased when butabarbital is combined with nitrazepam.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with ketoprofen.


The risk or severity of adverse effects can be increased when triamcinolone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when oxycodone is combined with nalbuphine.


The risk or severity of adverse effects can be increased when pergolide is combined with isoniazid.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with thalidomide.


The risk or severity of adverse effects can be increased when nicergoline is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when benzocaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when pergolide is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when morniflumate is combined with ketoprofen.


The risk or severity of adverse effects can be increased when metoprolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when prilocaine is combined with primidone.


The risk or severity of adverse effects can be increased when sulpiride is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with methazolamide.


The risk or severity of adverse effects can be increased when Icatibant is combined with amcinonide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Icatibant is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Nepafenac.


The risk or severity of adverse effects can be increased when amitriptyline is combined with procarbazine.


The risk or severity of adverse effects can be increased when pergolide is combined with colchicine.


The risk or severity of adverse effects can be increased when Ifenprodil is combined with diflunisal.


The risk or severity of adverse effects can be increased when nisoldipine is combined with nadolol.


The risk or severity of adverse effects can be increased when clozapine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with nimesulide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when alprazolam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with clomipramine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Tolcapone.


The risk or severity of adverse effects can be increased when midazolam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when midazolam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with HEROIN.


The risk or severity of adverse effects can be increased when Halazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with flunarizine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with dibucaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with indomethacin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Articaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with morphine.


The risk or severity of adverse effects can be increased when temazepam is combined with midazolam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Retigabine.


The risk or severity of adverse effects can be increased when risperidone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when sevoflurane is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with betamethasone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when alprazolam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with halcinonide.


The risk or severity of adverse effects can be increased when clozapine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when clozapine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Telithromycin is combined with oxycodone.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Propacetamol.


The risk or severity of adverse effects can be increased when clozapine is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with butalbital.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Nepafenac is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with sulpiride.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when estazolam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when floctafenine is combined with budesonide.


The risk or severity of adverse effects can be increased when sulpiride is combined with cetirizine.


The risk or severity of adverse effects can be increased when estazolam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when sulpiride is combined with protriptyline.


The risk or severity of adverse effects can be increased when trimeprazine is combined with thiopental.


The risk or severity of adverse effects can be increased when trandolapril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when betamethasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with tetracaine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Salsalate.


The risk or severity of adverse effects can be increased when thioridazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when propoxyphene is combined with amisulpride.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when nalbuphine is combined with quetiapine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when selegiline is combined with nadolol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Olsalazine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with bumetanide.


The risk or severity of adverse effects can be increased when midazolam is combined with cetirizine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Limaprost is combined with aspirin.


The risk or severity of adverse effects can be increased when midazolam is combined with protriptyline.


The risk or severity of adverse effects can be increased when Limaprost is combined with PHENPROCOUMON.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with Pirlindole.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with meprobamate.


The risk or severity of adverse effects can be increased when terconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when methadone is combined with acetazolamide.


The risk or severity of adverse effects can be increased when codeine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with tretinoin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Naftifine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with tiagabine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with zonisamide.


The risk or severity of adverse effects can be increased when chloroxine is combined with isradipine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with prazepam.


The risk or severity of adverse effects can be increased when diazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when trimipramine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with amitriptyline.


The risk or severity of adverse effects can be increased when loratadine is combined with dantrolene.


The risk or severity of adverse effects can be increased when ramipril is combined with meperidine.


The risk or severity of adverse effects can be increased when ramipril is combined with prazosin.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when biperiden is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when buspirone is combined with thiopental.


The risk or severity of adverse effects can be increased when Tolcapone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with felbamate.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when procaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Butethal.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Tramadol is combined with lidocaine.


The risk or severity of adverse effects can be increased when quinapril is combined with celecoxib.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when thioridazine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when thioridazine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when irbesartan is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when propranolol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with halcinonide.


The risk or severity of adverse effects can be increased when Nilotinib is combined with Flibanserin.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with difluprednate.


The risk or severity of adverse effects can be increased when nalbuphine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when nalbuphine is combined with quazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with prazepam.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with hydralazine.


The risk or severity of adverse effects can be increased when quazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Mometasone.


The risk or severity of adverse effects can be increased when Apremilast is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when loxapine is combined with butamben.


The risk or severity of adverse effects can be increased when diazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when diazepam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when diazepam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when Apremilast is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when bromazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when captopril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when linezolid is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when irbesartan is combined with Droxicam.


The risk or severity of adverse effects can be increased when tenoxicam is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when irbesartan is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when propantheline is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when minoxidil is combined with papaverine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Deferasirox.


The risk or severity of adverse effects can be increased when imipramine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when irbesartan is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when paroxetine is combined with amisulpride.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when ethopropazine is combined with morphine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with pimozide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with mepivacaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when estazolam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Pipamperone.


The risk or severity of adverse effects can be increased when flumethasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with 3,4-Dihydroxybenzaldehyde.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Propacetamol.


The risk or severity of adverse effects can be increased when flumethasone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when amobarbital is combined with clonidine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with oxycodone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ethopropazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Ramelteon.


The risk or severity of adverse effects can be increased when alprazolam is combined with clidinium.


The risk or severity of adverse effects can be increased when Arotinolol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Butethal is combined with Pipamperone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when minoxidil is combined with hydralazine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when loxapine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with DIPHENOXYLATE.